Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by P. J. Yazaki
Induction of in Vitro and in Vivo NK Cell Cytotoxicity Using High-Avidity Immunoligands Targeting Prostate-Specific Membrane Antigen in Prostate Carcinoma
Molecular Cancer Therapeutics
Cancer Research
Oncology
Quantitative ImmunoPET of Prostate Cancer Xenografts With 89Zr- And 124i-Labeled Anti-Psca A11 Minibody
Journal of Nuclear Medicine
Medicine
Nuclear Medicine
Radiology
Imaging
Related publications
The Application of Prostate Specific Membrane Antigen in CART‑cell Therapy for Treatment of Prostate Carcinoma (Review)
Oncology Reports
Medicine
Cancer Research
Oncology
In Vitro and in Vivo Evaluation of the Bifunctional Chelator NODIA-Me in Combination With a Prostate-Specific Membrane Antigen Targeting Vector
Nuclear Medicine and Biology
Cancer Research
Nuclear Medicine
Radiology
Molecular Medicine
Imaging
Auger Radiopharmaceutical Therapy Targeting Prostate-Specific Membrane Antigen in a Micrometastatic Model of Prostate Cancer
International Journal of Radiation Oncology Biology Physics
Oncology
Radiology
Cancer Research
Radiation
Nuclear Medicine
Imaging
Biochemical Characterization of Prostate-Specific Membrane Antigen From Canine Prostate Carcinoma Cells
Prostate
Oncology
Urology
Targeting Novel Antigens for Prostate Cancer Treatment: Focus on Prostate-Specific Membrane Antigen
Expert Opinion on Therapeutic Targets
Molecular Medicine
Drug Discovery
Clinical Biochemistry
Pharmacology
Prostate-Specific Membrane Antigen Heterogeneity and DNA Repair Defects in Prostate Cancer
European Urology
Urology
Prostate-Specific Membrane Antigen–directed Nanoparticle Targeting for Extreme Nearfield Ablation of Prostate Cancer Cells
Tumor Biology
Medicine
Cancer Research
Prostate-Specific Membrane Antigen (PSMA) Assembles a Macromolecular Complex Regulating Growth and Survival of Prostate Cancer Cells “In Vitro” and Correlating With Progression “In Vivo”
Oncotarget
Oncology
Prostate Specific Membrane Antigen-Based Therapeutics
